In vitro development of IVF‐derived bovine embryos following cytoplasmic microinjection for the episomal expression of the IGF2 gene
Autor: | Karine de Mattos, Felipe Ledur Ongaratto, Karine Campagnolo, Marcelo Bertolini, Camilo Andrés Peña Bello, Camila Freitas, José Luiz Rodrigues, Bruna Rodrigues Willhelm |
---|---|
Rok vydání: | 2020 |
Předmět: |
Microinjections
Genetic Vectors Green Fluorescent Proteins Embryonic Development Fertilization in Vitro Biology Green fluorescent protein Embryo Culture Techniques Andrology 03 medical and health sciences 0302 clinical medicine Endocrinology Insulin-Like Growth Factor II medicine Animals Blastocyst Microinjection 030219 obstetrics & reproductive medicine Zygote Expression vector Embryogenesis 0402 animal and dairy science Embryo 04 agricultural and veterinary sciences Embryo Mammalian 040201 dairy & animal science medicine.anatomical_structure embryonic structures Cattle Animal Science and Zoology Genomic imprinting Biotechnology |
Zdroj: | Reproduction in Domestic Animals. 55:574-583 |
ISSN: | 1439-0531 0936-6768 |
DOI: | 10.1111/rda.13654 |
Popis: | Important genomic imprinting changes usually occur following the in vitro production (IVP) of bovine embryos, especially in the imprinting pattern of components of the IGF system. This study aimed to evaluate the effects of a transient episomal overexpression of the IGF2 gene in bovine IVP embryos following embryo cytoplasmic microinjection (CMI) at the 1-cell stage on embryo survival, early and late developmental kinetics and morphological quality up to Day 7 of development. Selected cumulus-oocyte complexes (COCs) were matured and fertilized in vitro and subsequently segregated into six experimental groups: non-CMI control group and five CMI groups at increasing doses (0, 10, 20, 40 and 80 ng/μl) of a GFP vector built for the episomal expression of bovine IGF2. Zygote CMI was effective in delivering the expression vector into the ooplasm, irrespective of the groups, with 58% of positive GFP fluorescence in Day 7 blastocysts. Considering developmental rates and late embryo kinetics, the 10-ng/μl CMI vector dose promoted a lower blastocyst rate (10.4%), but for blastocysts at more advanced stages of development (93.0% blastocysts and expanded blastocysts), and higher number of cells (116.0 ± 3.0) than non-CMI controls (23.3%, 75.0% and 75.0 ± 6.8 were obtained, respectively). In conclusion, CMI at the 1-cell stage did not compromise subsequent in vitro development of surviving embryos, with the 10-ng/μl group demonstrating a possible growth-promoting effect of the IGF2 gene on embryo development, from the 1-cell to the blastocyst stage. |
Databáze: | OpenAIRE |
Externí odkaz: |